C3 Submits Comments to the FDA’s Oncology Drug Advisory Committee

The Food and Drug Administration’s (FDA) Oncology Drug Advisory Committee (ODAC) is meeting today to discuss whether the labels for Erbitux (cetuximab) and Vectibix (panitumumab) should include a mention of KRAS testing. The discussion at the meeting will have implications for future development of companion diagnostics. C3 President Carlea Bauman will be testifying during the public comment section: Continue reading…

Posted by Joe Arite on December 16th, 2008
Posted in: C3 News, Policy & Advocacy News, Research & Treatment News | 1 Comment »
Tags: Erbitux, FDA, KRAS, ODAC, Vectibix

Tina Kiser, C3 Advocate and Friend

Tina at 2008 Call-on Congress

C3 was dealt yet another blow in our fight against colorectal cancer. One of our advocates, Tina Kiser, passed away from this terrible disease over the weekend. I had the pleasure of meeting Tina at last year’s Call-On Congress. Her passion to end the pain and suffering felt by everyone touched by colorectal cancer was extremely visible in everything she did. Whether it was walking the halls of Congress or recruiting people to make phone calls during the Congressional Butt-In, Tina was determined to get things done.

Two of Tina’s fellow C3 advocates, Marilia Sardinha and Suzanne Lindley, remember their time with her:

Continue reading…

Posted by Joe Arite on December 12th, 2008
Posted in: C3 News | 1 Comment »

Register NOW for C3’s 3rd Annual Call-on Congress!

March 22-25, 2009
Washington, DC

Imagine yourself in the Halls of Congress…fighting for an end to colorectal cancer. It can happen. You CAN do it. Continue reading…

Posted by Joe Arite on October 16th, 2008
Posted in: C3 News, Policy & Advocacy News | 1 Comment »
Tags: Advocacy, Call on Congress

C3 Advocate Robb Kerr Dies

Robb Kerr

Robb Kerr, one of the first patient advocates to be part of C3, the Colorectal Cancer Coalition, died at home in Nashville, Tennesee on September 29, 2008.

First diagnosed with advanced colorectal cancer in 2002, Robb was treated in many cancer clinical trials and became an ardent supporter of cancer research.  He was a mentor to other cancer patients considering clinical trials at Vanderbilt-Ingram Cancer Center in Nashville. He also spoke out for the needs of people without health insurance and for universal health care. Continue reading…

Posted by Kate Murphy on October 1st, 2008
Posted in: C3 News, Research & Treatment News | No Comments »
Tags: patient advocates

Dr. Joel Tepper Honored with ASTRO Gold Medal

Dr. Joel Tepper

Joel E. Tepper, M.D., a member of the C3 Medical Advisory Network, has received the Gold Medal Award, the highest honor that the American Society for Radiation Therapy and Oncology (ASTRO) gives to its members. He received the medal during an awards ceremony on September 23, 2008 at ASTRO’s 50th Annual Meeting in Boston. Continue reading…

Posted by Kate Murphy on September 26th, 2008
Posted in: C3 News, Research & Treatment News | No Comments »